Literature DB >> 9267191

Activity levels and the relationship to lung function and nutritional status in children with cystic fibrosis.

G P Boucher1, L C Lands, J A Hay, L Hornby.   

Abstract

Cystic fibrosis is characterized by chronic obstructive lung disease and malnutrition. Previous studies have shown that nutritional status and lung function are limiting factors for exercise capacity. A reduced exercise capacity may in turn diminish activity levels. We evaluated whether the total time spent somewhat active (e.g., walking) or active (e.g., biking), as reported by the Habitual Activity Estimation Scale, was related to lung function, as evaluated by forced expiratory volume in one second (%predicted FEV1), and nutritional status, measured as body mass percentile, in 36 children with cystic fibrosis, aged 6 to 16 years. The Habitual Activity Estimation Scale questionnaires were completed by the parents for children younger than 12 years of age and by both the parent and the child, independently, for those 12 years and older. Patients had a body mass percentile of 99 +/- 15.2% and % predicted FEV1 of 85.7 +/- 20, with no differences between boys (15/36) and girls (21/36). Boys spent 8.1 hours and girls spent 7.5 hours (P > 0.1) being at least somewhat active. These values are similar to those reported for healthy boys and girls. In patients with significant lung disease (%predicted FEV1, < or = 75; n = 11), activity level (the time spent somewhat active or active) was related to nutritional status (r = 0.675; P = 0.02) but not to lung function (r = 0.21; P > 0.1). Activity level reported by patients 12 years of age and older was on average 24.1% higher (P < 0.05) than that reported by their parents, but the two reportings were related (r = 0.758; P = 0.004). These results suggest that activity level may be restricted by nutritional status in those patients with significant air flow limitation. We suggest that improving the nutritional status of cystic fibrosis patients may prevent decreases in activity levels and quality of life of these affected children.

Entities:  

Mesh:

Year:  1997        PMID: 9267191     DOI: 10.1097/00002060-199707000-00010

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  16 in total

1.  Peak oxygen uptake and mortality in children with cystic fibrosis.

Authors:  P Pianosi; J Leblanc; A Almudevar
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Eucapnic Voluntary Hyperventilation to Detect Exercise-Induced Bronchoconstriction in Cystic Fibrosis.

Authors:  Stephen E Kirkby; Don Hayes; Jonathan P Parsons; Clayton E Wisely; Ben Kopp; Karen S McCoy; John G Mastronarde
Journal:  Lung       Date:  2015-06-03       Impact factor: 2.584

3.  Validation of activity questionnaires in patients with cystic fibrosis by accelerometry and cycle ergometry.

Authors:  Katharina C Ruf; Sonja Fehn; Michèle Bachmann; Alexander Moeller; Kristina Roth; Susi Kriemler; Helge Hebestreit
Journal:  BMC Med Res Methodol       Date:  2012-04-03       Impact factor: 4.615

4.  Airflow limitation following cardiopulmonary exercise testing and heavy-intensity intermittent exercise in children with cystic fibrosis.

Authors:  Daniel Stevens; Patrick J Oades; Craig A Williams
Journal:  Eur J Pediatr       Date:  2014-08-14       Impact factor: 3.183

5.  Perceptions of physical activity in a group of adolescents with cystic fibrosis.

Authors:  Anne K Swisher; Mia Erickson
Journal:  Cardiopulm Phys Ther J       Date:  2008-12

6.  The evidence regarding exercise training in the management of cystic fibrosis: a systematic review.

Authors:  Michael J Shoemaker; Heather Hurt; Leah Arndt
Journal:  Cardiopulm Phys Ther J       Date:  2008-09

7.  Gender differences in habitual activity in children with cystic fibrosis.

Authors:  H C Selvadurai; C J Blimkie; P J Cooper; C M Mellis; P P Van Asperen
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

Review 8.  Management of osteoporosis in adults with cystic fibrosis.

Authors:  Travis M Hecker; Robert M Aris
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Growth hormone and exercise tolerance in patients with cystic fibrosis.

Authors:  Matthias Hütler; Ralph Beneke
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

10.  Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial.

Authors:  Vanessa J Poustie; Jayne E Russell; Ruth M Watling; Deborah Ashby; Rosalind L Smyth
Journal:  BMJ       Date:  2006-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.